Sometribove Zinc Suspension
64 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
64
Total Reports
2
Deaths Reported
310.0%
Death Rate
Active Ingredients
Sometribove Zinc Suspension
Administration Routes
UnknownSubcutaneousOralIntradermal
Species Affected
Cattle 55
Human 5
Unknown 4
Most Affected Breeds
Holstein-Friesian also known as Holstein 39
Unknown 9
Jersey 7
Cattle (other) 7
Holstein-Friesian - Swedish 1
Cattle (unknown) 1
Most Reported Reactions
INEFFECTIVE, PRODUCTION (MILK) 12
Alteration of milk quality 10
Reduced conception rate 6
Milk production decrease 6
Mastitis NOS 5
Injection site swelling 5
Milk production increase 4
Injection site abscess 3
Death 3
Mammary gland disorder NOS 3
Female reproductive tract disorder NOS 2
Lack of efficacy - NOS 2
Outcome Breakdown
Outcome Unknown
35 (56.5%)
Recovered with Sequela
12 (19.4%)
Recovered/Normal
11 (17.7%)
Ongoing
2 (3.2%)
Died
2 (3.2%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.